Search research articles
Contact Us
Filters
Showing results (111-120 of 149) with videos related to
Page
of 15
Sort By:
European Journal of Haematology
|
October 22, 2020
Daratumumab for relapsed AL amyloidosis-When cumulative real-world data precedes clinical trials: A multisite study and systematic literature review
Tamir Shragai, Moshe Gatt, Noa Lavie, et al.
Leukemia Research
|
June 2, 2019
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia
Tamar Tadmor, Ilana Levy, Yair Herishanu, et al.
Leukemia Research
|
March 5, 2018
Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome
Chezi Ganzel, Ory Rouvio, Irit Avivi, et al.
Haematologica
|
July 29, 2021
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Ohad Benjamini, Lior Rokach, Gilad Itchaki, et al.
Palliative Medicine
|
March 25, 2021
Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy
Liza Barki-Harrington, Orna Baron-Epel, Adir Shaulov, et al.
Leukemia & Lymphoma
|
September 8, 2022
Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study Group
Chezi Ganzel, Svetlana Trestman, Shai Levi, et al.
Leukemia & Lymphoma
|
October 10, 2025
Expert consensus opinion on the management of hairy cell leukemia in elderly patients
Tamar Tadmor, Judit Demeter, Andrei Fagarasanu, et al.
British Journal of Haematology
|
October 7, 2022
Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
Tamir Shragai, Hila Magen, Noa Lavi, et al.
Blood Advances
|
December 5, 2024
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study
Ofir Wolach, Itai Levi, Boaz Nachmias, et al.
British Journal of Haematology
|
June 8, 2017
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients
Eldad J Dann, Osnat Bairey, Rachel Bar-Shalom, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 149) with videos related to
Sort By:
Page
of 15
European Journal of Haematology
|
October 22, 2020
Daratumumab for relapsed AL amyloidosis-When cumulative real-world data precedes clinical trials: A multisite study and systematic literature review
Tamir Shragai, Moshe Gatt, Noa Lavie, et al.
Leukemia Research
|
June 2, 2019
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia
Tamar Tadmor, Ilana Levy, Yair Herishanu, et al.
Leukemia Research
|
March 5, 2018
Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome
Chezi Ganzel, Ory Rouvio, Irit Avivi, et al.
Haematologica
|
July 29, 2021
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Ohad Benjamini, Lior Rokach, Gilad Itchaki, et al.
Palliative Medicine
|
March 25, 2021
Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy
Liza Barki-Harrington, Orna Baron-Epel, Adir Shaulov, et al.
Leukemia & Lymphoma
|
September 8, 2022
Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study Group
Chezi Ganzel, Svetlana Trestman, Shai Levi, et al.
Leukemia & Lymphoma
|
October 10, 2025
Expert consensus opinion on the management of hairy cell leukemia in elderly patients
Tamar Tadmor, Judit Demeter, Andrei Fagarasanu, et al.
British Journal of Haematology
|
October 7, 2022
Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
Tamir Shragai, Hila Magen, Noa Lavi, et al.
Blood Advances
|
December 5, 2024
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study
Ofir Wolach, Itai Levi, Boaz Nachmias, et al.
British Journal of Haematology
|
June 8, 2017
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients
Eldad J Dann, Osnat Bairey, Rachel Bar-Shalom, et al.
Page
of 15